Evidence map›Paper›PMID 41959728›Full record

ArticleHemaSphere2026

Efficacy and safety of steroid-sparing strategy in the treatment of AIHA associated with KSHV/HHV-8 positive multicentric Castleman disease.

Yannick Dieudonné, Clément Gourguechon, Romain Stammler, Florence Delestre, Boris Sorin, Bertrand Dunogué, Guillaume Dumas, Guillemette Fouquet, Anne-Marie Ronchetti, Romain Paule and 15 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in HemaSphere, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Yannick DieudonnéDepartment of Clinical Immunology and Internal Medicine National Reference Center for Systemic Autoimmune Diseases (RESO), CHU Strasbourg Strasbourg France.
Clément GourguechonDepartment of Hematology Centre Hospitalo-Universitaire d'Amiens Amiens France.
Romain StammlerLaboratory of Lymphocyte Activation and Susceptibility to EBV Infection, Imagine Institute Université Paris Cité Paris France.ORCID https://orcid.org/0000-0002-0533-5964
Florence DelestreDepartment of Internal Medicine, Hôpital Cochin Université Paris Cité Paris France.
Boris SorinDepartment of Internal Medicine, Hôpital Cochin Université Paris Cité Paris France.
Bertrand DunoguéDepartment of Internal Medicine, Hôpital Cochin Université Paris Cité Paris France.
Guillaume DumasDepartment of Intensive Care CHU Grenoble-Alpes Grenoble France.
Guillemette FouquetDepartment of Hematology Centre Hospitalier Sud-Francilien Corbeil-Essonnes France.
Anne-Marie RonchettiDepartment of Hematology Centre Hospitalier Sud-Francilien Corbeil-Essonnes France.
Romain PauleDepartment of Internal Medicine Hôpital Foch Suresnes France.
Pascal MelianiDepartment of Infectious and Tropical Diseases Centre Hospitalier de Mayotte Mamoudzou Mayotte.
Nathalie PansuDepartment of Infectious and Tropical Diseases CHU Gui de Chauliac Montpellier France.
Rodolphe BuzeleDepartment of Infectious and Tropical Diseases General Hospital St-Brieuc France.
Robin NoelDepartment of Hematology Institut Paoli-Calmettes Marseille France.ORCID https://orcid.org/0000-0002-7048-5491
Jehane FadlallahClinical Immunology Department, Hôpital Saint Louis Université Paris Cité Paris France.
Marion MalphettesClinical Immunology Department, Hôpital Saint Louis Université Paris Cité Paris France.
Emilie CorvilainClinical Immunology Department, Hôpital Saint Louis Université Paris Cité Paris France.
Véronique MeigninNational Reference Center for Castleman Disease, Hôpital Saint Louis Université Paris Cité Paris France.
Constance GuillaudDepartment d'Aval des Urgences, Mondor Hospital Université Paris-Est Créteil Créteil France.
Antoine DossierDepartment of Internal Medicine Bichat Hospital, AP-HP. Nord - Université Paris Cité Paris France.
Jérémie DionDepartment of Clinical Immunology and Internal Medicine CHU Toulouse-Oncopole Toulouse France.
Laurence GérardClinical Immunology Department, Hôpital Saint Louis Université Paris Cité Paris France.
Eric OksenhendlerClinical Immunology Department, Hôpital Saint Louis Université Paris Cité Paris France.
Lionel GalicierNational Reference Center for Castleman Disease, Hôpital Saint Louis Université Paris Cité Paris France.
David BoutboulLaboratory of Lymphocyte Activation and Susceptibility to EBV Infection, Imagine Institute Université Paris Cité Paris France.ORCID https://orcid.org/0000-0002-5006-8279

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41959728
PMCPMC13058919

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.